...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Medicinal Chemistry >Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches
【24h】

Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches

机译：在药物发现项目上设计PXR活动：对基于结构的方法，实证和计算方法的综述

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This perspective discusses the role of pregnane xenobiotic receptor (PXR) in drug discovery and the impact of its activation on CYP3A4 induction. The use of structural biology to reduce PXR activity on drug discovery projects has become more common in recent years. Analysis of this work highlights several important molecular interactions, and the resultant structural modifications to reduce PXR activity are summarized. The computational approaches undertaken to support the design of new drugs devoid of PXR activation potential are also discussed. Finally, the SAR of empirical design strategies to reduce PXR activity is reviewed, and the key SAR transformations are discussed and summarized. In conclusion, this perspective demonstrates that PXR activity can be greatly diminished or negated on active drug discovery projects with the knowledge now available. This perspective should be useful to anyone who seeks to reduce PXR activity on a drug discovery project.
机译：这一观点讨论了孕烷异源受体（PXR）在药物发现中的作用及其激活对CYP3A4诱导的影响。近年来，利用结构生物学降低药物发现项目中的PXR活性已变得越来越普遍。对这项工作的分析强调了几个重要的分子相互作用，并总结了由此产生的降低PXR活性的结构修饰。本文还讨论了用于支持设计缺乏PXR激活潜能的新药的计算方法。最后，回顾了减少PXR活性的经验设计策略的SAR，并对关键的SAR转换进行了讨论和总结。总之，这一观点表明，在现有知识的情况下，在活跃的药物发现项目中，PXR活性可能会大大降低或被否定。这一观点对任何试图在药物发现项目中减少PXR活性的人都应该有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号